Ocean Biomedical Inc.
0.62
-0.06 (-9.32%)
At close: Jan 14, 2025, 3:59 PM
0.61
-0.85%
After-hours Jan 14, 2025, 06:01 PM EST
undefined%
Bid 0.6
Market Cap 21.59M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.95
PE Ratio (ttm) -0.65
Forward PE n/a
Analyst Buy
Ask 0.62
Volume 62,007
Avg. Volume (20D) 239,596
Open 0.67
Previous Close 0.68
Day's Range 0.60 - 0.67
52-Week Range 0.46 - 7.79
Beta undefined

About OCEA

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatm...

Industry Biotechnology
Sector Healthcare
IPO Date Nov 8, 2021
Employees 9
Stock Exchange NASDAQ
Ticker Symbol OCEA

Analyst Forecast

According to 2 analyst ratings, the average rating for OCEA stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 50.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts